Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Statland

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 3, 2021
Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating StudyStacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Journal of Neuromuscular Diseases|June 14, 2021
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD TrialRichard S Finkel, Craig M McDonald, H Lee Sweeney, et al.
Translational Neurodegeneration|October 29, 2025
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseasesGang Wu, Wenan Chen, Joanne Wuu, et al.
Brain : a Journal of Neurology|September 13, 2023
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophyRichard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Neurology. Clinical Practice|December 28, 2018
Consensus-based care recommendations for adults with myotonic dystrophy type 1Tetsuo Ashizawa, Cynthia Gagnon, William J Groh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2021
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, Martin R Turner, , et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 3, 2021
Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating StudyStacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Journal of Neuromuscular Diseases|June 14, 2021
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD TrialRichard S Finkel, Craig M McDonald, H Lee Sweeney, et al.
Translational Neurodegeneration|October 29, 2025
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseasesGang Wu, Wenan Chen, Joanne Wuu, et al.
Brain : a Journal of Neurology|September 13, 2023
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophyRichard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Neurology. Clinical Practice|December 28, 2018
Consensus-based care recommendations for adults with myotonic dystrophy type 1Tetsuo Ashizawa, Cynthia Gagnon, William J Groh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2021
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, Martin R Turner, , et al.
Pageof 4